Business

Latest News

Getting Ophthalmic Biosimilars to Market Continues to Prove Difficult
Getting Ophthalmic Biosimilars to Market Continues to Prove Difficult

March 27th 2023

Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have during a session at AMCP 2023.

doctor filling orange syringe
A Long Time Coming: Dr Sophia Humphreys Details What’s Coming Down the Biosimilar Pipeline

March 23rd 2023

laboratory with researchers
Samsung Bioepis’ Stelara Biosimilar Proves Successful in Phase 1 Study

March 20th 2023

globe
Biorationality: A Dr Sarfaraz Niazi Column—A New Perspective on Biosimilars' Role Within Big Pharma

March 13th 2023

eye on pharma banner
Eye on Pharma: FDA, EMA Accept Biosimilar Applications; Biosimilar Trials Begin

March 9th 2023

Video Interviews
Podcasts
CfB podcast banner
cfb podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.